RDInvesting Provides Stock Research on Forest Oil and Rex Energy
Continue ReadingTag: stock-market
Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation
Five Star Equities Provides Stock Research on Celldex Therapeutics and DARA Biosciences
Continue Reading
Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success
Five Star Equities Provides Stock Research on Exelixis and Lexicon Pharmaceuticals
Continue Reading
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
RDInvesting Provides Stocks Research on Cadence Pharmaceuticals and Opexa Therapeutics
Continue Reading
Expanding Pipelines Sends Margin Between West Texas Intermediate and Brent Crude to Narrowest in 8 Months
RDInvesting Provides Stock Research on Bill Barrett and Goodrich Petroleum
Continue Reading
Cyprus Proposes Tax on Deposits — Concerns Mount That Other Struggling Countries May Follow
RDInvesting Provides Stock Research on Lloyds Banking Group and National Bank of Greece
Continue Reading
Financial Sector Dragged Down by More Euro-Zone Concerns — Cyprus Proposes Tax on Deposits
RDInvesting Provides Stock Research on Morgan Stanley and Goldman Sachs
Continue Reading
FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval after Just 1 Round of Testing
Five Star Equities Provides Stock Research on Oncolytics Biotech and XOMA
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
RDInvesting Provides Stocks Research on Protalix BioTherapeutics and Supernus Pharmaceuticals
Continue Reading
New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry-s Growth in 2012
Five Star Equities Provides Stock Research on ImmunoCellular and Nektar
Continue Reading